Form D · Pharmaceuticals
Vapogenix, Inc.
Houston, TX · CIK 0001628848
Offering snapshot reported Jan 11, 2018 · SEC filing
- Reported sold
- $1.63M Offering amount: $1.63M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $20K Reported outside-investor minimum
- First sale
- Dec 29, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 11, 2018 | Initial | $1,633,764 | No comparison | 7 | SEC filing |
| Dec 8, 2016 | Amendment | $8,203,133 | $225,003vs Sep 14, 2016 | 37 | SEC filing |
| Sep 14, 2016 | Initial | $7,978,130 | No comparison | 35 | SEC filing |
| Dec 23, 2014 | Initial | $2,100,000 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-303001
Source: Form D, filed Jan 11, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Danguole Altman | Director, Executive |
| Motter Clarice | Executive |
| George Davitt | Director |
| Bruce Given | Director |
| Clay M Heighten | Director |
| Christopher Jorgensen | Director |
| Christopher Jorgeson | Director |
| Marc Loev | Director |
| Danguole Spakevicius | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
8285 El Rio St., Suite 170
Houston, TX, 77054
Houston, TX, 77054